EUVIMEDEUVIMED entdecken
Open Access

A Chemoinformatic-Guided Synthesis of a Spleen-Expressing mRNA Lipid Nanoparticle Platform

Eshan A Narasipura iD, Yutian Ma iD, Palas Balakdas Tiwade iD, Rachel VanKeulen-Miller, Vincent Fung, Owen S Fenton iD

Bioconjugate Chemistry · 15.01.2025 · 36 (1) · 54-65

DOI: 10.1021/acs.bioconjchem.4c00419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 20.12.2024. Verfasst von Eshan A Narasipura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Spleen, RNA, Messenger, Nanoparticles, Lipids. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA lipid nanoparticles (LNPs) are a powerful technology that are actively being investigated for their ability to prevent, treat, and study disease. However, a major limitation remains: achieving extrahepatic mRNA expression. The development of new carriers could enable the expression of mRNA in non-liver targets, thus expanding the utility of mRNA-based medicines. In this study, we use a combination of chemoinformatic-guided material synthesis and design of experiment optimization for the development of a spleen-expressing lipid nanoparticle (SE-LNP). We begin with the synthesis of a novel cholesterol derivative followed by SE-LNP formulation and design of experiment-guided optimization to identify three lead SE-LNPs. We then evaluate their in vitro delivery mechanism, in vivo biodistribution, and protein expression in mice, ultimately achieving spleen-preferential expression. The goal of this paper is thus to create LNPs that preferentially express mRNA in the spleen upon intravenous delivery, demonstrating the potential of LNPs to modulate gene expression in extrahepatic tissues for disease treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpleenRNA, MessengerNanoparticlesLipidsAnimalsMiceTissue DistributionHumansLiposomes

Substanzen

RNA, MessengerLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Eshan A Narasipura, Yutian Ma, Palas Balakdas Tiwade, Owen S Fenton

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NIBIB NIH HHS
  • NCI NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Narasipura, E. A., Ma, Y., Tiwade, P. B., VanKeulen-Miller, R., Fung, V., & Fenton, O. S. (2025). A Chemoinformatic-Guided Synthesis of a Spleen-Expressing mRNA Lipid Nanoparticle Platform. Bioconjugate Chemistry, 36(1), 54-65. https://doi.org/10.1021/acs.bioconjchem.4c00419

Vancouver

Narasipura EA, Ma Y, Tiwade PB, VanKeulen-Miller R, Fung V, Fenton OS. A Chemoinformatic-Guided Synthesis of a Spleen-Expressing mRNA Lipid Nanoparticle Platform. Bioconjugate Chemistry. 2025;36(1):54-65. doi:10.1021/acs.bioconjchem.4c00419

BibTeX
@article{Narasipura2025,
  author = {Narasipura, Eshan A and Ma, Yutian and Tiwade, Palas Balakdas and VanKeulen-Miller, Rachel and Fung, Vincent and Fenton, Owen S},
  title = {A Chemoinformatic-Guided Synthesis of a Spleen-Expressing mRNA Lipid Nanoparticle Platform},
  journal = {Bioconjugate Chemistry},
  year = {2025},
  volume = {36},
  number = {1},
  pages = {54--65},
  doi = {10.1021/acs.bioconjchem.4c00419}
}
Kostenlos starten →